Rizi Ai, 1 David L. Boyle, 1 Wei Wang,corresponding author 1 and Gary S. Firesteincorresponding author 1
doi : 10.1002/acr2.11231
ACR Open Rheumatol. 2021 Mar; 3(3): 127–132.
To study epigenetic patterns in T lymphocytes that accumulate in the rheumatoid arthritis (RA) synovium, we characterized DNA methylation of CD3+ T cells in peripheral blood and synovial tissue in patients with RA and osteoarthritis (OA).
Bibi Ayesha,corresponding author 1 Anand Kumthekar, 1 Ruchi Jain, 1 Sneha Patel, 1 Manish Ramesh, 1 Denisa E Ferastraoaru, 1 Golda Hudes, 1 Merhunisa Karagic, 1 Sheema Zafar, 1 Rachel Bartash, 1 Natalia Vasquez?Canizares, 1 Elizabeth Kitsis, 1 Clement Tagoe, 1 Dawn M. Wahezi, 1 Tamar Rubinstein, 1 and Anna Broder 1
doi : 10.1002/acr2.11220
ACR Open Rheumatol. 2021 Mar; 3(3): 133–137.
Patients with coronavirus disease 2019 (COVID?19) can progress to a state of unregulated inflammation called cytokine storm syndrome (CSS). We describe formation and operation of a COVID?19 multidisciplinary consultation service that was allowed to individualize treatment for critically ill patients with COVID?19 during the pandemic.
Kristina H?rnberg,corresponding author 1 Jeremy Pomeroy, 2 Camilla Sandberg, 1 Lars ?ngstr?m, 1 Anna S?dergren, 1 and Bj?rn Sundstr?m 1
doi : 10.1002/acr2.11225
ACR Open Rheumatol. 2021 Mar; 3(3): 138–146.
We aimed to determine relationships between objectively measured nightly sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical activity (MVPA) with risk factors for cardiovascular disease (CVD) in patients with early rheumatoid arthritis (RA). Furthermore, we aimed to estimate consequences for these risk factors of theoretical displacements of 30 minutes per day in one behavior with the same duration of time in another.
Sara K. Tedeschi,corresponding author 1 Piotr S. Sobiesczyzk, 1 Julia A. Ford, 2 Michael A. DiIorio, 1 and William P. Docken 1
doi : 10.1002/acr2.11227
ACR Open Rheumatol. 2021 Mar; 3(3): 147–153.
Vascular ultrasound (VUS) is a first?line test for giant cell arteritis (GCA) in Europe but has been of limited use in the United States. We report clinical experience with a multidisciplinary model of VUS for the evaluation of GCA at a large US medical center.
E. R. Vina,corresponding author 1 M. J. Hannon, 2 C. Quinones, 1 L. R. M. Hausmann, 3 S. A. Ibrahim, 4 J. Dagnino, 1 and C. K. Kwoh 1
doi : 10.1002/acr2.11235
ACR Open Rheumatol. 2021 Mar; 3(3): 154–163.
The objective of this study was to evaluate how patient knowledge and beliefs regarding nonsteroidal anti?inflammatory drugs (NSAIDs) may influence the use of NSAIDs for osteoarthritis (OA).
Puneet Bajaj,corresponding author 1 Usha Kollipara, 2 Rama Koganti, 2 Dan (Claire) Wang, 1 Navreet Chennu, 3 Deepa Bhat, 2 Jacqueline Mutz, 2 Duwayne Willett, 1 Jason Fish, 1 and David Karp 1
doi : 10.1002/acr2.11233
ACR Open Rheumatol. 2021 Mar; 3(3): 164–172.
Rheumatoid arthritis (RA) disease activity assessment is critical for treatment decisions and treat to target (T2T) outcomes. Utilization of the electronic medical record (EMR) and techniques to improve the routine capture of disease activity measures in clinical practice are not well described. We leveraged a Lean Six Sigma (LSS) approach, a data?driven five?step process improvement and problem?solving methodology, coupled with EMR modifications to evaluate improvement in disease activity documentation and patient outcomes.
Joel M. Kremer,corresponding author 1 Clifton O. Bingham, III, 2 Laura C. Cappelli, 2 Jeffrey D. Greenberg, 3 Ann M. Madsen, 4 Jamie Geier, 4 Jose L. Rivas, 5 Alina M. Onofrei, 6 Christine J. Barr, 6 Dimitrios A. Pappas, 7 Heather J. Litman, 6 Kimberly J. Dandreo, 6 Andrea B. Shapiro, 8 Carol A. Connell, 9 and Arthur Kavanaugh 10
doi : 10.1002/acr2.11232
ACR Open Rheumatol. 2021 Mar; 3(3): 173–184.
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We compared 5?year adverse event (AE) incidence rates (IRs) between patients initiating tofacitinib and those initiating new biological disease?modifying antirheumatic drugs (bDMARDs) within the United States (US) Corrona RA registry.
Maria A. Lopez?Olivo, 1 Jude K. des Bordes, 2 Heather Lin, 1 Robert J. Volk, 1 Tara Rizvi, 3 and Maria E. Suarez?Almazorcorresponding author 1
doi : 10.1002/acr2.11222
ACR Open Rheumatol. 2021 Mar; 3(3): 185–195.
The objective of this study was to assess the efficacy of self?administered patient educational tools in improving knowledge and behaviors for the management of knee osteoarthritis.
Jason M. Springer, 1 Mohamad A. Kalot, 2 Nedaa M. Husainat, 3 Kevin W. Byram, 1 Anisha B. Dua, 4 Karen E. James, 5 Yih Chang Lin, 6 Marat Turgunbaev, 7 Alexandra Villa?Forte, 8 Andy Abril, 9 Carol Langford, 8 Mehrdad Maz, 10 Sharon A. Chung, 11 and Reem A. Mustafacorresponding author 10
doi : 10.1002/acr2.11230
ACR Open Rheumatol. 2021 Mar; 3(3): 196–205.
The aim of this systemic review is to compare different treatments for patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) to inform evidence?based recommendations for the American College of Rheumatology (ACR)/Vasculitis Foundation (VF) Vasculitis Management Guidelines.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟